Skip to main content
TKNO
NASDAQ Life Sciences

Alpha Teknova's 2025 10-K Reveals 7.4% Revenue Growth, Net Loss Narrows to $17.3M

feedReported by Wiseek News
Sentiment info
Positive
Importance info
7
Price
$2.38
Mkt Cap
$127.399M
52W Low
$1.91
52W High
$7.48
Market data snapshot near publication time

summarizeSummary

Alpha Teknova released its fiscal 2025 annual results via its 10-K filing, reporting $40.5 million in revenue, a 7.4% increase from the prior year. The company demonstrated significant operational improvements, with gross profit expanding by 85.9% to $13.441 million and gross margin recovering to 33.2%. Although Alpha Teknova recorded a net loss of $17.3 million, this represents a 35.5% improvement year-over-year. These results suggest a positive trend in the company's financial performance and efficiency, which could positively influence investor sentiment. Traders will monitor the sustainability of revenue growth and margin expansion as the company continues to invest in its infrastructure.

At the time of this announcement, TKNO was trading at $2.38 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $127.4M. The 52-week trading range was $1.91 to $7.48. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


show_chartPrice Chart

Share this article

Copied!

feed TKNO - Latest Insights

TKNO
Apr 21, 2026, 5:22 PM EDT
Filing Type: DEF 14A
Importance Score:
8
TKNO
Mar 02, 2026, 5:15 PM EST
Source: Wiseek News
Importance Score:
7
TKNO
Mar 02, 2026, 5:10 PM EST
Filing Type: 10-K
Importance Score:
8
TKNO
Feb 26, 2026, 4:08 PM EST
Filing Type: 8-K
Importance Score:
7